Related Experiment Video
Updated: Feb 11, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema in Intubated Patients: Case Series and
Erin K Yeung1,2, Haritha Saikumar3, Jose Castaneda-Nerio3
1Department of Pharmacy Services, South Texas Veterans Health Care System, 7400 Merton Minter, San Antonio, TX 78229, USA.
Icatibant may help intubated patients with angiotensin-converting enzyme inhibitor-induced angioedema extubate sooner. Early administration is recommended, though further trials are needed to confirm benefits in critically ill patients.
Area of Science:
- Pharmacology
- Critical Care Medicine
- Emergency Medicine
Background:
- Angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema is a potentially life-threatening condition.
- Intubated patients with severe ACEI-induced angioedema present unique management challenges.
- Limited evidence exists regarding the efficacy of specific treatments in this critical subgroup.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

